CNBX Pharmaceutical (CNBX) Total Assets by Year
CNBX Pharmaceutical Inc closed fiscal year 2025 with $18K in total assets, $2.5M in total liabilities and -$2.5M in shareholder equity. Total assets fell 41.3% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters CNBX Pharmaceutical Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CNBX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $18K-41.3% | $31K-93.7% | $499K-38.5% | $811K-73.7% | $3.1M+38.7% | $2.2M-85.4% | $15.2M+376.7% | $3.2M-12.4% | $3.6M+15238.8% | $24K-17.4% | $29K-74.9% | $114K+57.0% | $73K | N/A | N/A |
| Total Liabilities | $2.5M+0.1% | $2.5M-0.2% | $2.5Mn/m | -$821K-164.5% | $1.3M+179.9% | $455K+3.6% | $439K-18.6% | $539K-91.8% | $6.6M+1238.9% | $491K+45.2% | $338K+356.3% | $74K-58.4% | $178K | N/A | N/A |
| Total Equity | -$2.5Mn/m | -$2.5Mn/m | -$2.0M-223.6% | $1.6M-9.6% | $1.8M+2.3% | $1.8M-88.0% | $14.7M+457.3% | $2.6Mn/m | -$2.9Mn/m | -$467Kn/m | -$310K-872.5% | $40Kn/m | -$105Kn/m | -$49Kn/m | -$47K |
CNBX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $13K-31.3% | $15K-70.6% | $11K-50.0% | $18K-41.3% | $19K-76.7% | $51K-69.1% | $22K-94.2% | $31K-93.7% | $80K-87.9% | $164K-64.5% | $387K-36.4% | $499K-38.5% |
| Total Liabilities | $2.7M+4.6% | $2.5M-2.8% | $2.6M+1.9% | $2.5M+0.1% | $2.6M+0.9% | $2.6M+3.9% | $2.5M+2.2% | $2.5M-0.2% | $2.5M-1.4% | $2.5M+2.0% | $2.5M-3.9% | $2.5Mn/m |
| Total Equity | -$2.7Mn/m | -$2.5Mn/m | -$2.6Mn/m | -$2.5Mn/m | -$2.5Mn/m | -$2.6Mn/m | -$2.5Mn/m | -$2.5Mn/m | -$2.5Mn/m | -$2.4Mn/m | -$2.1Mn/m | -$2.0M-223.6% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More CNBX Pharmaceutical Inc financials
Frequently Asked Questions
CNBX Pharmaceutical Inc closed fiscal year 2025 with $18K in total assets, $2.5M in total liabilities and -$2.5M in shareholder equity.
CNBX Pharmaceutical Inc (CNBX) total assets fell by 41.3% year over year, from $31K to $18K in fiscal year 2025.
CNBX Pharmaceutical Inc (CNBX) reported $13K in total assets in Q3 2026. This represents a decrease of 31.3% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what CNBX Pharmaceutical Inc (CNBX) reported on that line in every period on record.